Loxo Oncology (acquired)
E133655
UNEXPLORED
Loxo Oncology (acquired) is a biotechnology company focused on developing targeted cancer therapies, particularly for tumors driven by specific genetic alterations.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.